- September 29, 2023New ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ will improve patient lives by advancing groundbreaking diagnostic and prognostic technologies.
- July 5, 2023
ARUP Blood Services Implements Changes in Response to New FDA Guidelines on Blood Donor Assessment
The FDA now recommends the same assessment questions for all donors, regardless of gender or sexual orientation. ARUP Blood Services is one of the first donor centers to update processes in response. - June 29, 2023ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
- April 12, 2023
ARUP Laboratories Chooses Gestalt’s PathFlow Solution for Its Strategic Digital Initiatives
ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives. - January 10, 2023
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding
Efforts to train more medical laboratory scientists have been greatly boosted by $3 million in federal funds for a clinical lab training center that ARUP will build with the University of Utah. - January 9, 2023
Individuals Who Lived and Worked in Parts of Europe Now Eligible to Donate Blood
The U.S. Food and Drug Administration (FDA) has updated its guidelines to allow individuals who lived or worked in the United Kingdom, France, or Ireland to donate blood and platelets. - December 1, 2022
ARUP Honored With Utah Business Magazine’s Best Companies To Work For Award
ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year. - November 9, 2022
ARUP Announces Successful Completion of CAP ISO 15189 Assessment
ARUP’s International Organization for Standardization (ISO) 15189 accreditation assessment has successfully concluded, and results confirm the consistently high quality of ARUP’s operations. - September 26, 2022
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy
The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe. - September 14, 2022
NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in Europe
NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership. - July 25, 2022
ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments
ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox. - May 9, 2022
New Executive Appointments Position ARUP Laboratories for Future Growth
Jonathan Genzen, MD, PhD, has been named chief medical officer and Adam Barker, PhD, has been named chief operations officer as part of a realignment of executive responsibilities.